Cargando…
DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine
Human lung cancer H1299 (p53-null) cells often display enhanced susceptibility to chemotherapeutics comparing to A549 (p53-wt) cells. However, little is known regarding to the association of DNA damage-response (DDR) pathway heterogeneity with drug sensitivity in these two cells. We investigated the...
Autores principales: | Yang, Sheng-Yong, Li, Yi, An, Guo-Shun, Ni, Ju-Hua, Jia, Hong-Ti, Li, Shu-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032248/ https://www.ncbi.nlm.nih.gov/pubmed/29843366 http://dx.doi.org/10.3390/ijms19061587 |
Ejemplares similares
-
Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells
por: Zhang, Shijie, et al.
Publicado: (2014) -
GATA3 Exerts Distinct Transcriptional Functions to Regulate Radiation Resistance in A549 and H1299 Cells
por: Wang, Rui, et al.
Publicado: (2022) -
Differences in the Relative Abundance of ProBDNF and Mature BDNF in A549 and H1299 Human Lung Cancer Cell Media
por: Dorandish, Sadaf, et al.
Publicado: (2021) -
microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells
por: CHEN, CHANGJIN, et al.
Publicado: (2015) -
The Effect of Beta Adrenoreceptor Blockers on Viability and Cell Colony Formation of Non-Small Cell Lung Cancer Cell Lines A549 and H1299
por: Sidorova, Marina, et al.
Publicado: (2022)